260 related articles for article (PubMed ID: 26348104)
1. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.
Smits LP; Coolen BF; Panno MD; Runge JH; Nijhof WH; Verheij J; Nieuwdorp M; Stoker J; Beuers UH; Nederveen AJ; Stroes ES
Radiology; 2016 Mar; 278(3):782-91. PubMed ID: 26348104
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study.
Bastati N; Feier D; Wibmer A; Traussnigg S; Balassy C; Tamandl D; Einspieler H; Wrba F; Trauner M; Herold C; Ba-Ssalamah A
Radiology; 2014 Jun; 271(3):739-47. PubMed ID: 24576046
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Differential Diagnosis of Liver Iron Contents in Nonalcoholic Steatohepatitis and Simple Steatosis Using Multiecho Dixon Magnetic Resonance Imaging.
Kim TH; Jeong CW; Jun HY; Kim YR; Kim JY; Lee YH; Yoon KH
Acad Radiol; 2019 Jun; 26(6):766-774. PubMed ID: 30143402
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous MR quantification of hepatic fat content, fatty acid composition, transverse relaxation time and magnetic susceptibility for the diagnosis of non-alcoholic steatohepatitis.
Leporq B; Lambert SA; Ronot M; Vilgrain V; Van Beers BE
NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28678410
[TBL] [Abstract][Full Text] [Related]
6. Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide.
Cheong H; Lee SS; Lee JS; Kim J; Kim SW; Lee WJ
J Magn Reson Imaging; 2015 May; 41(5):1218-27. PubMed ID: 24916329
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Gd-EOB-DTPA-enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitis.
Wu Z; Matsui O; Kitao A; Kozaka K; Koda W; Kobayashi S; Ryu Y; Minami T; Sanada J; Gabata T
J Magn Reson Imaging; 2013 May; 37(5):1137-43. PubMed ID: 23172731
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation.
Smits LP; Tiessens F; Zheng KH; Stroes ES; Nederveen AJ; Coolen BF
Atherosclerosis; 2017 Aug; 263():211-218. PubMed ID: 28662398
[TBL] [Abstract][Full Text] [Related]
9. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
10. Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
Pulli B; Wojtkiewicz G; Iwamoto Y; Ali M; Zeller MW; Bure L; Wang C; Choi Y; Masia R; Guimaraes AR; Corey KE; Chen JW
Radiology; 2017 Aug; 284(2):390-400. PubMed ID: 28358240
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.
Tang A; Tan J; Sun M; Hamilton G; Bydder M; Wolfson T; Gamst AC; Middleton M; Brunt EM; Loomba R; Lavine JE; Schwimmer JB; Sirlin CB
Radiology; 2013 May; 267(2):422-31. PubMed ID: 23382291
[TBL] [Abstract][Full Text] [Related]
13. Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats.
Okada M; Katsube T; Kumano S; Kagawa Y; Araki T; Tsuda N; Okuaki T; Imaoka I; Tanigawa N; Ishii K; Murakami T
Acta Radiol; 2011 Jul; 52(6):658-64. PubMed ID: 21498305
[TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
[TBL] [Abstract][Full Text] [Related]
15. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
[TBL] [Abstract][Full Text] [Related]
16. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging.
Aguirre DA; Behling CA; Alpert E; Hassanein TI; Sirlin CB
Radiology; 2006 May; 239(2):425-37. PubMed ID: 16641352
[TBL] [Abstract][Full Text] [Related]
17. Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.
Bastati N; Perkonigg M; Sobotka D; Poetter-Lang S; Fragner R; Beer A; Messner A; Watzenboeck M; Pochepnia S; Kittinger J; Herold A; Kristic A; Hodge JC; Traussnig S; Trauner M; Ba-Ssalamah A; Langs G
Eur Radiol; 2023 Nov; 33(11):7729-7743. PubMed ID: 37358613
[TBL] [Abstract][Full Text] [Related]
18. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
[TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
20. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]